COC(=O)CN(CC1O[C@@H]2OC(C)(C)O[C@@H]2C1N=[N+]=[N-])C(=O)OCc1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?